A Phase 1 Randomized, Double Blind, Placebo Controlled Rectal Safety and Acceptability Study of Tenofovir 1% Gel (MTN-007)

Ian Mcgowan; Craig Hoesley; Ross D. Cranston; Philip Andrew; Laura Janocko; James Y. Dai; Alex Carballo-Dieguez; Ratiya Kunjara Na Ayudhya; Jeanna Piper; Florian Hladik; Ken Mayer

doi:10.1371/journal.pone.0060147

Loading metrics

Open Access

Peer-reviewed

Research Article

A Phase 1 Randomized, Double Blind, Placebo Controlled Rectal Safety and Acceptability Study of Tenofovir 1% Gel (MTN-007)

Ian Mcgowan ,

* E-mail: imcgowan@pitt.edu

Affiliations University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania, United States of America, Microbicide Trials Network, Magee-Womens Research Institute, Pittsburgh, Pennsylvania, United States of America
⨯
Craig Hoesley,

Affiliation University of Alabama, Birmingham, Alabama, United States of America
⨯
Ross D. Cranston,

Affiliation University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania, United States of America
⨯
Philip Andrew,

Affiliation FHI 360, Research Triangle Park, Durham, North Carolina, United States of America
⨯
Laura Janocko,

Affiliation Microbicide Trials Network, Magee-Womens Research Institute, Pittsburgh, Pennsylvania, United States of America
⨯
James Y. Dai,

Affiliations University of Washington, Seattle, Washington, United States of America, Statistical Center for HIV/AIDS Research and Prevention, Fred Hutchinson Cancer Research Center, Seattle, Washington, United States of America
⨯
Alex Carballo-Dieguez,

Affiliation Columbia University, New York, New York, United States of America
⨯
Ratiya Kunjara Na Ayudhya,

Affiliation Microbicide Trials Network, Magee-Womens Research Institute, Pittsburgh, Pennsylvania, United States of America
⨯
Jeanna Piper,

Affiliation Division of AIDS, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, United States of America
⨯
Florian Hladik,

Affiliations University of Washington, Seattle, Washington, United States of America, Statistical Center for HIV/AIDS Research and Prevention, Fred Hutchinson Cancer Research Center, Seattle, Washington, United States of America
⨯
Ken Mayer

Affiliation Fenway Health, Boston, Massachusetts, United States of America
⨯

A Phase 1 Randomized, Double Blind, Placebo Controlled Rectal Safety and Acceptability Study of Tenofovir 1% Gel (MTN-007)

Ian Mcgowan,
Craig Hoesley,
Ross D. Cranston,
Philip Andrew,
Laura Janocko,
James Y. Dai,
Alex Carballo-Dieguez,
Ratiya Kunjara Na Ayudhya,
Jeanna Piper,
Florian Hladik

Published: April 3, 2013
https://doi.org/10.1371/journal.pone.0060147

Reader Comments (0)

Post a new comment on this article

Subject Areas
?

For more information about PLOS Subject Areas, click here.
We want your feedback. Do these Subject Areas make sense for this article? Click the target next to the incorrect Subject Area and let us know. Thanks for your help!

Rectum
Is the Subject Area "Rectum" applicable to this article?

Thanks for your feedback.
Adverse events
Is the Subject Area "Adverse events" applicable to this article?

Thanks for your feedback.
Biopsy
Is the Subject Area "Biopsy" applicable to this article?

Thanks for your feedback.
Histology
Is the Subject Area "Histology" applicable to this article?

Thanks for your feedback.
Gene expression
Is the Subject Area "Gene expression" applicable to this article?

Thanks for your feedback.
Microarrays
Is the Subject Area "Microarrays" applicable to this article?

Thanks for your feedback.
Microbicides
Is the Subject Area "Microbicides" applicable to this article?

Thanks for your feedback.
T cells
Is the Subject Area "T cells" applicable to this article?

Thanks for your feedback.